These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2540747)

  • 21. Modulation of 4'-(9-acridinylamino)methanesulfon-m-anisidide-induced, topoisomerase II-mediated DNA cleavage by gossypol.
    Adlakha RC; Ashorn CL; Chan D; Zwelling LA
    Cancer Res; 1989 Apr; 49(8):2052-8. PubMed ID: 2539251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suramin is an inhibitor of DNA topoisomerase II in vitro and in Chinese hamster fibrosarcoma cells.
    Bojanowski K; Lelievre S; Markovits J; Couprie J; Jacquemin-Sablon A; Larsen AK
    Proc Natl Acad Sci U S A; 1992 Apr; 89(7):3025-9. PubMed ID: 1313577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antitumor agents. 125. New 4 beta-benzoylamino derivatives of 4'-O-demethyl-4-desoxypodophyllotoxin and 4 beta-benzoyl derivatives of 4'-O-demethylpodophyllotoxin as potent inhibitors of human DNA topoisomerase II.
    Zhou XM; Wang ZQ; Chen HX; Cheng YC; Lee KH
    Pharm Res; 1993 Feb; 10(2):214-9. PubMed ID: 8384366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitors of DNA topoisomerase II induce topological changes in an archaebacterial plasmid in vivo.
    Sioud M; Baldacci G; de Recondo AM; Forterre P
    Biochem Pharmacol; 1988 May; 37(9):1879-80. PubMed ID: 2837247
    [No Abstract]   [Full Text] [Related]  

  • 25. Cross-resistance of novobiocin-resistant BHK cell line to topoisomerase II inhibitors.
    Ishida R; Nishizawa M; Nishimoto T; Takahashi T
    Somat Cell Mol Genet; 1988 Sep; 14(5):489-97. PubMed ID: 2845588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quinolones share a common interaction domain on topoisomerase II with other DNA cleavage-enhancing antineoplastic drugs.
    Elsea SH; Westergaard M; Burden DA; Lomenick JP; Osheroff N
    Biochemistry; 1997 Mar; 36(10):2919-24. PubMed ID: 9062121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA topoisomerase II is the molecular target of bisdioxopiperazine derivatives ICRF-159 and ICRF-193 in Saccharomyces cerevisiae.
    Ishida R; Hamatake M; Wasserman RA; Nitiss JL; Wang JC; Andoh T
    Cancer Res; 1995 Jun; 55(11):2299-303. PubMed ID: 7757979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA topoisomerase I as a site of action for 10-hydroxycamptothecin in human promyelocytic leukemia cells.
    Ling YH; Andersson BS; Nelson JA
    Cancer Biochem Biophys; 1990 Jan; 11(1):23-30. PubMed ID: 2159843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of antibiotics and antitumor agents on the relaxation activity of Pisum sativum leaf chloroplast topoisomerase I.
    Zagariya AM; Sitailo LA
    Arch Biochem Biophys; 1995 Jun; 320(1):177-81. PubMed ID: 7793978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-activity relationships of 9-anilinoacridines as inhibitors of human DNA topoisomerase II.
    Figgitt DP; Denny WA; Gamage SA; Ralph RK
    Anticancer Drug Des; 1994 Jun; 9(3):199-208. PubMed ID: 8031452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bacteriophage T4 DNA topoisomerase is the target of antitumor agent 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) in T4-infected Escherichia coli.
    Huff AC; Leatherwood JK; Kreuzer KN
    Proc Natl Acad Sci U S A; 1989 Feb; 86(4):1307-11. PubMed ID: 2537494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antitumor agents. 100. Inhibition of human DNA topoisomerase II by cytotoxic ether and ester derivatives of podophyllotoxin and alpha-peltatin.
    Thurston LS; Imakura Y; Haruna M; Li DH; Liu ZC; Liu SY; Cheng YC; Lee KH
    J Med Chem; 1989 Mar; 32(3):604-8. PubMed ID: 2537424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antitumor agents. 120. New 4-substituted benzylamine and benzyl ether derivatives of 4'-O-demethylepipodophyllotoxin as potent inhibitors of human DNA topoisomerase II.
    Zhou XM; Wang ZQ; Chang JY; Chen HX; Cheng YC; Lee KH
    J Med Chem; 1991 Dec; 34(12):3346-50. PubMed ID: 1662724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of DNA topoisomerase II catalytic activity by the antiviral agents 7-chloro-1,3-dihydroxyacridone and 1,3,7-trihydroxyacridone.
    Vance JR; Bastow KF
    Biochem Pharmacol; 1999 Aug; 58(4):703-8. PubMed ID: 10413309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A rational design strategy of the novel topoisomerase II inhibitors for the synthesis of the 4-O-(2-pyrazinecarboxylic)-4'-demethylepipodophyllotoxin with antitumor activity by diminishing the relaxation reaction of topoisomerase II-DNA decatenation.
    Zhao W; Chen L; Li HM; Wang DJ; Li DS; Chen T; Yuan ZP; Tang YJ
    Bioorg Med Chem; 2014 Jun; 22(11):2998-3007. PubMed ID: 24775914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons.
    D'Arpa P; Beardmore C; Liu LF
    Cancer Res; 1990 Nov; 50(21):6919-24. PubMed ID: 1698546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antitumor agents, 130, Novel 4 beta-arylamino derivatives of 3',4'-didemethoxy-3',4'-dioxo-4-deoxypodophyllotoxin as potent inhibitors of human DNA topoisomerase II.
    Zhang YL; Shen YC; Wang ZQ; Chen HX; Guo X; Cheng YC; Lee KH
    J Nat Prod; 1992 Aug; 55(8):1100-11. PubMed ID: 1331331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antitumor agents. 123. Synthesis and human DNA topoisomerase II inhibitory activity of 2'-chloro derivatives of etoposide and 4 beta-(arylamino)-4'-O-demethylpodophyllotoxins.
    Hu H; Wang ZQ; Liu SY; Cheng YC; Lee KH
    J Med Chem; 1992 Mar; 35(5):866-71. PubMed ID: 1312600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A temperature sensitive topoisomerase II allele confers temperature dependent drug resistance on amsacrine and etoposide: a genetic system for determining the targets of topoisomerase II inhibitors.
    Nitiss JL; Liu YX; Hsiung Y
    Cancer Res; 1993 Jan; 53(1):89-93. PubMed ID: 8380128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutations in the gyrB domain of eukaryotic topoisomerase II can lead to partially dominant resistance to etoposide and amsacrine.
    Nitiss JL; Vilalta PM; Wu H; McMahon J
    Mol Pharmacol; 1994 Oct; 46(4):773-7. PubMed ID: 7969059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.